Amryt Pharma Plc Overview

Amryt Pharma Plc Cost of Revenue

Cost of Revenue analysis for AMYT.

Quarterly Cost of Revenue

$33.70M

↑ 23.61% YoY

As of Sep 30, 2022

Annual Cost of Revenue (TTM)

$127.03M

↑ 18.92% YoY

Trailing 12 months ending Sep 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin